Q1004 – New technology intraocular lens category 4 as defined in federal register notice

Long description

New technology intraocular lens category 4 as defined in federal register notice

Short description

Ntiol category 4

Pricing indicator

57 Other carrier priced

Medicare coverage

D Special coverage instructions apply

BETOS category

D1F Prosthetic/Orthotic devices

Added

July 1, 1999

Last change

October 1, 2003 – No change

Nearby Q codes

• Q0514 – Pharmacy dispensing fee for inhalation drug(s); per 90 days
• Q0515 – Injection, sermorelin acetate, 1 microgram
• Q0516 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days
• Q0517 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days
• Q0518 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days
• Q0519 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days
• Q0520 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days
• Q0521 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
• Q1005 – New technology intraocular lens category 5 as defined in federal register notice
• Q2004 – Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
• Q2009 – Injection, fosphenytoin, 50 mg phenytoin equivalent
• Q2017 – Injection, teniposide, 50 mg
• Q2026 – Injection, radiesse, 0.1 ml
• Q2028 – Injection, sculptra, 0.5 mg
• Q2034 – Influenza virus vaccine, split virus, for intramuscular use (agriflu)
• Q2035 – Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)